Sponsors
The bill aims to speed funding, improve transparency, and better target SBIR/STTR support for small businesses and innovators, but it does so at the cost of added administrative burden, potential short-term uncertainty, and a measurable risk to review rigor unless safeguards and extensions are implemented.
Small businesses and researchers will likely receive decisions and funding faster through a pilot to target ~90-day notice-to-funding intervals and alternative peer-review options, speeding commercialization.
Applicants, Congress, and taxpayers get clearer, comparable data on agency review times and program performance (average/median review times and multi-year trends), improving transparency and accountability.
GAO review and required reporting can lead agencies to improve outreach and program alignment, helping new entrants and underrepresented small businesses access SBIR/STTR support and increasing commercialization success.
Accelerated or alternative peer-review procedures risk reducing scientific rigor or consistency, which could lead to lower-quality awards and potential safety/efficacy concerns.
New reporting requirements, GAO reviews, and pilot implementation will increase administrative burden and costs for agencies and staff time, potentially diverting resources from program delivery and raising taxpayer costs.
The pilot authority sunsets in 2030, so any speed or process gains may be temporary and create uncertainty for applicants and agency planning unless Congress extends the pilot.
Based on analysis of 5 sections of legislative text.
Strengthens SBIR/STTR reporting and oversight, adds agency proposal-timing metrics, and requires an NIH pilot to speed award processing toward a ~90-day target.
Introduced August 19, 2025 by Morgan McGarvey · Last progress August 19, 2025
Makes modest edits to SBIR/STTR statutory text and tightens oversight and timeliness for federal small business research awards. It directs the Government Accountability Office to produce a 3-year assessment of SBIR/STTR performance on diversity and commercialization, requires the SBA to include a new 11-year timeliness metric (average and median review time) per participating agency in its reports, and directs the NIH Director to launch a pilot to shorten NIH SBIR/STTR award processing with a goal of moving from notice to funding to about 90 days and to test alternative peer review approaches.